Correlation Between Generation Bio and Lantern Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Generation Bio and Lantern Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Generation Bio and Lantern Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Generation Bio Co and Lantern Pharma, you can compare the effects of market volatilities on Generation Bio and Lantern Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Generation Bio with a short position of Lantern Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Generation Bio and Lantern Pharma.

Diversification Opportunities for Generation Bio and Lantern Pharma

-0.1
  Correlation Coefficient

Good diversification

The 3 months correlation between Generation and Lantern is -0.1. Overlapping area represents the amount of risk that can be diversified away by holding Generation Bio Co and Lantern Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lantern Pharma and Generation Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Generation Bio Co are associated (or correlated) with Lantern Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lantern Pharma has no effect on the direction of Generation Bio i.e., Generation Bio and Lantern Pharma go up and down completely randomly.

Pair Corralation between Generation Bio and Lantern Pharma

Given the investment horizon of 90 days Generation Bio Co is expected to under-perform the Lantern Pharma. But the stock apears to be less risky and, when comparing its historical volatility, Generation Bio Co is 1.38 times less risky than Lantern Pharma. The stock trades about -0.29 of its potential returns per unit of risk. The Lantern Pharma is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  327.00  in Lantern Pharma on December 30, 2024 and sell it today you would earn a total of  28.00  from holding Lantern Pharma or generate 8.56% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Generation Bio Co  vs.  Lantern Pharma

 Performance 
       Timeline  
Generation Bio 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Generation Bio Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's forward indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
Lantern Pharma 

Risk-Adjusted Performance

Insignificant

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Lantern Pharma are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Lantern Pharma displayed solid returns over the last few months and may actually be approaching a breakup point.

Generation Bio and Lantern Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Generation Bio and Lantern Pharma

The main advantage of trading using opposite Generation Bio and Lantern Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Generation Bio position performs unexpectedly, Lantern Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lantern Pharma will offset losses from the drop in Lantern Pharma's long position.
The idea behind Generation Bio Co and Lantern Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Other Complementary Tools

Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk